.STUDY FEATURE.16 October 2024.
In the NIAGARA hearing, the add-on of perioperative durvalumab to regular treatment for muscle-invasive bladder cancer enhanced event-free as well as generally survival, denoting a brand-new procedure possibility for this disorder.